Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh PP, Roberts LR, et al. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2014;11:45–54.
   PubMed Web of Science ®Google Scholar
• Lou J, Zhang L, Lv S, et al. Biomarkers for Hepatocellular Carcinoma. Biomark Cancer. 2017;9:1–9.
   PubMedGoogle Scholar
• Schutte K, Schulz C, Link A, et al. Current biomarkers for hepatocellular carcinoma: surveillance, diagnosis and prediction of prognosis. World J Hepatol. 2015;7:139–149.
   PubMed Web of Science ®Google Scholar
• Tsuchiya N, Sawada Y, Endo I, et al. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10573–10583.
   PubMed Web of Science ®Google Scholar
• Asada K, Kotake Y, Asada R, et al. LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J Biomed Biotechnol. 2006;2006:17142.
   PubMedGoogle Scholar
• Song Z, Zhou Z, Chen T, et al. S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice. J Nutr Biochem. 2003;14:591–597.
   PubMed Web of Science ®Google Scholar
• Stefanska B, Huang J, Bhattacharyya B, et al. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res. 2011;71:5891–5903.
   PubMed Web of Science ®Google Scholar
• Stefanska B, Bouzelmat A, Huang J, et al. Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes. PLoS One. 2013;8:e68439.
   PubMed Web of Science ®Google Scholar
• Stefanska B, Cheishvili D, Suderman M, et al. Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets. Clin Cancer Res. 2014;20:3118–3132.
   PubMed Web of Science ®Google Scholar
• Stefanska B, Suderman M, Machnes Z, et al. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. Carcinogenesis. 2013;34:2738–2749.
   PubMed Web of Science ®Google Scholar
• Cheishvili D, Stefanska B, Yi C, et al. A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness. Oncotarget. 2015;6:33253–33268.
   PubMedGoogle Scholar
• Jones PA, Issa JP, Baylin S. Targeting the cancer epigenome for therapy. Nat Reviews Genet. 2016;17:630–641.
   PubMed Web of Science ®Google Scholar
• Mayol G, Martin-Subero JI, Rios J, et al. DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS One. 2012;7:e48401.
   PubMed Web of Science ®Google Scholar
• Lubecka K, Kurzava L, Flower K, et al. Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. Carcinogenesis. 2016;37:656–668.
   PubMed Web of Science ®Google Scholar
• Cheishvili D, Boureau L, Szyf M. DNA demethylation and invasive cancer: implications for therapeutics. Br J Pharmacol. 2015;172:2705–2715.
   PubMed Web of Science ®Google Scholar
• Pereira MA, Wang W, Kramer PM, et al. Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice. Toxicol Sci. 2004;77:243–248.
   PubMed Web of Science ®Google Scholar
• Hernandez-Vargas H, Castelino J, Silver MJ, et al. Exposure to aflatoxin B1 in utero is associated with DNA methylation in white blood cells of infants in The Gambia. Int J Epidemiol. 2015;44:1238–1248.
   PubMed Web of Science ®Google Scholar
• Al-Moghrabi N, Nofel A, Al-Yousef N, et al. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. BMC Cancer. 2014;14:830.
   PubMed Web of Science ®Google Scholar
• deVos T, Tetzner R, Model F, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55:1337–1346.
   PubMed Web of Science ®Google Scholar
• Campan M, Moffitt M, Houshdaran S, et al. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One. 2011;6:e28141.
   PubMed Web of Science ®Google Scholar
• Mah WC, Lee CG. DNA methylation: potential biomarker in hepatocellular carcinoma. Biomark Res. 2014;2:5.
   PubMedGoogle Scholar
• Huang ZH, Hu Y, Hua D, et al. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma. Exp Mol Pathol. 2011;91:702–707.
   PubMed Web of Science ®Google Scholar
• Xu RH, Wei W, Krawczyk M, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater. 2017;16:1155–1161.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Guo X, Loomba R, et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology. 2010;139:1567–76,76 e1-6.
   PubMed Web of Science ®Google Scholar
• Friso S, Udali S, Guarini P, et al. Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk. Cancer Epidemiol Biomarkers Prev. 2013;22:348–355.
   PubMed Web of Science ®Google Scholar
• Huang WY, Su LJ, Hayes RB, et al. Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2012;21:2014–2021.
   PubMed Web of Science ®Google Scholar
• Ji HX, Zhao Q, Pan JH, et al. Association of BLCA-4 hypomethylation in blood leukocyte DNA and the risk of bladder cancer in a Chinese population. Pathol Oncol Res. 2013;19:205–210.
   PubMed Web of Science ®Google Scholar
• Brennan K, Garcia-Closas M, Orr N, et al. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res. 2012;72:2304–2313.
   PubMed Web of Science ®Google Scholar
• Kao WY, Yang SH, Liu WJ, et al. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers. Mol Carcinog. 2017;56:425–435.
   PubMed Web of Science ®Google Scholar
• Wu HC, Shen J, Yang HI, et al. Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan. World J Hepatol. 2016;8:301–306.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yan H, Zhang J. Blood DNA methylation markers in potentially identified Chinese patients with hepatocellular carcinoma. Pak J Pharm Sci. 2016;29:1451–1456.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. American association for the study of liver D. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
   PubMed Web of Science ®Google Scholar
• Cheishvili D, Stefanska B, Yi C, et al. A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness. Oncotarget. 2015;6.
   PubMedGoogle Scholar
• Colella S, Shen L, Baggerly KA, et al. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques. 2003;35:146–150.
   PubMed Web of Science ®Google Scholar
• Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc. 2007;2:2265–2275.
   PubMed Web of Science ®Google Scholar
• Adalsteinsson BT, Gudnason H, Aspelund T, et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One. 2012;7:e46705.
   PubMed Web of Science ®Google Scholar
• Reinius LE, Acevedo N, Joerink M, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One. 2012;7:e41361.
   PubMed Web of Science ®Google Scholar
• Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.
   PubMed Web of Science ®Google Scholar
• Flanagan JM, Brook MN, Orr N, et al. Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study. Cancer Epidemiol Biomarkers Prev. 2015;24:221–229.
   PubMed Web of Science ®Google Scholar
• Zhang F, Fan YC, Mu NN, et al. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection. J Viral Hepat. 2014;21:241–250.
   PubMed Web of Science ®Google Scholar
• Vandamme J, Volkel P, Rosnoblet C, et al. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells. Mol Cell Proteomics. 2011;10:M110 002642.
   PubMed Web of Science ®Google Scholar
• Tsukada Y, Fang J, Erdjument-Bromage H, et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006;439:811–816.
   PubMed Web of Science ®Google Scholar
• Xu XZ, Garcia MV, Li TY, et al. Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod Pathol. 2010;23:187–196.
   PubMed Web of Science ®Google Scholar
• Bristow JM, Sellers MH, Majumdar D, et al. The Rho-family GEF Asef2 activates Rac to modulate adhesion and actin dynamics and thereby regulate cell migration. J Cell Sci. 2009;122:4535–4546.
   PubMed Web of Science ®Google Scholar
• Detchokul S, Williams ED, Parker MW, et al. Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol. 2014;171:5462–5490.
   PubMed Web of Science ®Google Scholar
• Saint-Pol J, Billard M, Dornier E, et al. New insights into the tetraspanin Tspan5 using novel monoclonal antibodies. J Biol Chem. 2017;292:9551–9566.
   PubMed Web of Science ®Google Scholar
• Heit C, Jackson BC, McAndrews M, et al. Update of the human and mouse SERPIN gene superfamily. Hum Genomics. 2013;7:22.
   PubMed Web of Science ®Google Scholar
• Qian X, Kim JK, Tong W, et al. DPPA5 supports pluripotency and reprogramming by regulating NANOG turnover. Stem Cells. 2016;34:588–600.
   PubMed Web of Science ®Google Scholar
• Lyukmanova EN, Shenkarev ZO, Shulepko MA, et al. NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1. J Biol Chem. 2011;286:10618–10627.
   PubMed Web of Science ®Google Scholar
• Costa Mdo C, Teixeira-Castro A, Constante M, et al. Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet. 2006;51:645–651.
   PubMed Web of Science ®Google Scholar
• Li YJ, Deng J, Mayhew GM, et al. Investigation of the PARK10 gene in Parkinson disease. Ann Hum Genet. 2007;71:639–647.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Y, Liu Z, et al. Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. FEBS Open Bio. 2016;6:1227–1237.
   PubMed Web of Science ®Google Scholar
• van Veldhoven K, Polidoro S, Baglietto L, et al. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics. 2015;7:67.
   PubMed Web of Science ®Google Scholar
• Cyr-Depauw C, Northey JJ, Tabaries S, et al. Chordin-like 1 suppresses bone morphogenetic protein 4-induced breast cancer cell migration and invasion. Mol Cell Biol. 2016;36:1509–1525.
   PubMed Web of Science ®Google Scholar
• Ramirez-Valle F, Badura ML, Braunstein S, et al. Mitotic raptor promotes mTORC1 activity, G(2)/M cell cycle progression, and internal ribosome entry site-mediated mRNA translation. Mol Cell Biol. 2010;30:3151–3164.
   PubMed Web of Science ®Google Scholar
• Berinstein NL. Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J Clin Oncol. 2002;20:2197–2207.
   PubMed Web of Science ®Google Scholar
• Ladd AN, Charlet N, Cooper TA. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol. 2001;21:1285–1296.
   PubMed Web of Science ®Google Scholar
• Cimmino F, Formicola D, Capasso M. Dualistic role of BARD1 in cancer. Genes. 2017;8:375.
   Web of Science ®Google Scholar
• Gao Q, Chen X, Duan H, et al. FXYD6: a novel therapeutic target toward hepatocellular carcinoma. Protein Cell. 2014;5:532–543.
   PubMed Web of Science ®Google Scholar
• Futyma K, Miotla P, Rozynska K, et al. Expression of genes encoding extracellular matrix proteins: a macroarray study. Oncol Rep. 2014;32:2349–2353.
   PubMed Web of Science ®Google Scholar
• Maeder ML, Angstman JF, Richardson ME, et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol. 2013;31:1137–1142.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Petropoulos S, Liu J, et al. The signature of liver cancer in immune cells DNA methylation. Clin Epigenetics. 2018;10:8.
   PubMed Web of Science ®Google Scholar
• Shi M, Chen MS, Sekar K, et al. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma. Eur J Cancer. 2014;50:928–936.
   PubMed Web of Science ®Google Scholar
• Sakai Y, Honda M, Fujinaga H, et al. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients. Cancer Res. 2008;68:10267–10279.
   PubMed Web of Science ®Google Scholar
• Weon JL, Potts PR. The MAGE protein family and cancer. Curr Opin Cell Biol. 2015;37:1–8.
   PubMed Web of Science ®Google Scholar
• Miharada K, Sigurdsson V, Karlsson S. Dppa5 improves hematopoietic stem cell activity by reducing endoplasmic reticulum stress. Cell Rep. 2014;7:1381–1392.
   PubMed Web of Science ®Google Scholar
• Vanaja DK, Ballman KV, Morlan BW, et al. PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. Clin Cancer Res. 2006;12:1128–1136.
   PubMed Web of Science ®Google Scholar
• Iwamori T, Iwamori N, Matsumoto M, et al. Identification of KIAA1210 as a novel X-chromosome-linked protein that localizes to the acrosome and associates with the ectoplasmic specialization in testes. Biol Reprod. 2017;96:469–477.
   PubMed Web of Science ®Google Scholar
• Barchitta M, Quattrocchi A, Maugeri A, et al. LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis. PLoS One. 2014;9:e109478.
   PubMed Web of Science ®Google Scholar